Soaring demand for GLP-1 presents challenges for pharma manufacturers
Anti-obesity medication is emerging as the latest pharma megatrend. However, the increasing demand for these semaglutide drugs needs to be backed by a strong packaging supply chain that can provide easy-to-use injectables in large quantities.
